Picture courtesy The Indian Express
New Delhi: The Drugs Controller General of India (DCGI) has granted emergency use authorization to the COVID-19 vaccine Covovax for 12-17 years age group, PTI reported on Wednesday quoting official sources.
Covovax, the Indian version of US-developed Novavax, is manufactured in this country by Serun Institute of India.
It is the fourth COVID vaccine to receive regulator’s nod for use among under-18 age group.
The other three are Bharat Biotech’s Covaxin, which is being used to vaccinate those aged between 15 and 18 years after getting clearance last December; Zydus Cadila’s ZyCov-D which became the first one to be cleared by DCGI for those above 12 in August 2021; Biological E’s Corbevax for 12-18 years approved last month.
DCGI gave the nod to Covovax for emergency use authorization among adults on December 28, 2021, but it’s yet to be included in India’s vaccination drive.
Mumbai: Television actress Hina Khan, who is battling breast cancer, recently met host Salman Khan…
Mumbai: Following reports of his alleged link-up with bassist Mohini Dey, renowned music composer AR…
Mumbai: The love story of actors Tamannaah Bhatia and Vijay Varma has not been clandestine.…
Puri: Shree Jagannath Temple Administration (SJTA) has received the report of the Ratna Bhandar’s GPR-GPS…
With his debut novel ‘The Other Side of the Rainbow’ published recently, Niranjan Nayak, an…
Bhubaneswar: Odisha outplayed Chhattisgarh 4-1 on Saturday to seal a berth in the final round…
Mumbai: The Telangana government’s notice barring him from singing songs promoting alcohol and drugs at…
Bhubaneswar: Prime Minister Narendra Modi will participate in the ‘Odisha Parba 2024’ programme on Sunday…